Vectibix (panitumumab) Important Safety Information from Amgen as approved by the Irish Medicines Board
18 July 2012
Important Safety Information communication from Amgen on the association of panitumumab with life-threatening and fatal infectious complications of severe skin reactions including necrotising fasciitis.
Important Safety Information Vectibix (panitumumab)